INTRODUCTION
============

The physical properties of a biological membrane are highly dependent on the lipid composition, which shows tremendous variation between different membranes and dependence on conditions ([@B13]). This variation is responsible for the plasticity of biomembranes, which plays a role in cellular adaptation to the environment and allows for cellular processes such as energy storage, signaling, transport, and membrane fusion and fission ([@B13]; [@B1]; [@B17]).

Membrane fluidity is an important physical property, which is to a large extent determined by the ratio of saturated versus unsaturated fatty acids ([@B35]). Membrane fluidity is essential for maintaining the membrane barrier and for optimal functioning of membrane proteins ([@B54]; [@B36]). The presence of *cis*-double bonds in membrane lipid acyl chains causes disturbances in the acyl chain packing, which result in a much lower gel--to--liquid crystalline phase transition temperature of the membrane. A poikilothermic organism like the yeast *Saccharomyces cerevisiae* readily adapts the degree of desaturation of its acyl chains when shifted to another growth temperature to sustain membrane fluidity ([@B36]). The degree of desaturation of membrane lipids also depends on the function of the membrane they constitute. For example, the inner mitochondrial membrane harboring the enzyme complexes of the respiratory chain contains a higher amount of unsaturated phospholipid acyl chains than the plasma membrane that shields the cell from the extracellular milieu ([@B51]). Accordingly, the increase in overall fatty acid desaturation observed following a shift of yeast cells from fermentable to nonfermentable carbon source reflects the full development of the mitochondrial network ([@B56]).

The yeast fatty acid profile is considerably less complex than its mammalian or plant counterparts, which contain a wide variation of fatty acids differing in length and degree of unsaturation. It consists mainly of C16 and C18 fatty acids bearing either one or no double bond. Fatty acid synthesis in *S. cerevisiae* is initiated by the acetyl-CoA carboxylase Aac1p and continued by the cytosolic multienzyme fatty acid synthase complex consisting of Fas1p and Fas2p, yielding acyl-CoA\'s with an acyl chain length of 16 or 18 carbon atoms ([@B55]). The endoplasmic reticulum (ER)--based fatty acid elongases Elo1p, Elo2p, and Elo3p can elongate the acyl-CoA\'s up to C26. Although essential, the very long acyl chains are very low in abundance ([@B46]).

Monounsaturated fatty acids account for ∼70--80% of total fatty acids and are synthesized from saturated fatty acyl-CoA substrates by the ER-resident Δ9-fatty acid desaturase Ole1p. Yeast can modulate the degree of acyl chain desaturation by varying the level of Ole1p expression. The expression of Ole1p is regulated at the level of transcription by temperature, carbon source, the presence of fatty acids in the growth medium, and oxygen levels ([@B36]). Transcriptional activation and mRNA stability of Ole1p requires ubiquitin-mediated cleavage of the homodimeric ER membrane proteins Spt23p and Mga2p by the 26S proteasome ([@B22]).

In a screen for gene products involved in acyl chain remodeling of the major membrane lipid phosphatidylcholine (PC; [@B3]), we identified the glycerol-3-phosphate (G3P) acyltransferase Sct1p/Gat2p. The *SCT1* gene was first characterized as a multicopy suppressor of a choline transport mutant also defective in phosphatidylethanolamine (PE) methylation ([@B37]), hence the name suppressor of choline transport 1. The 86-kDa enzyme Sct1p transfers acyl chains to the *sn*-1 position of G3P or dihydroxyacetonephosphate in the first committed step of glycerophospholipid synthesis, that is, the production of lysophosphatidic acid (lyso-PA; [@B60]). The homologous protein Gpt2p/Gat1p catalyzes the same reactions, and deletion of *SCT1* and *GPT2* is synthetically lethal. Both enzymes are integral membrane phosphoproteins localized to the ER ([@B5]).

In the present study, the analysis of *SCT1* deletion and overexpression strains demonstrates that Sct1p is a novel regulator of fatty acid desaturation by competing with the desaturase Ole1p for C16:0-CoA and sequestering C16:0 in lipids. The activity of Sct1p is regulated posttranslationally by phosphorylation. Moreover, the first component regulating Sct1p phosphorylation is reported, and the functional relevance of the phosphorylation of Sct1p is illustrated in wild-type yeast. To our knowledge, this is the first time that an acyltransferase is implicated in cellular fatty acid homeostasis.

RESULTS
=======

Deletion of *SCT1* changes the molecular species profile of PC by impairing acyl chain remodeling
-------------------------------------------------------------------------------------------------

In a screen for gene products required for acyl chain remodeling of PC, we examined the effect of deleting genes encoding (potential) acyltransferases on the molecular species profile of PC in a *pct1* strain. Cells lacking Pct1p---the enzyme catalyzing the rate-limiting step of the CDP-choline pathway---rely on the methylation of PE for the synthesis of PC and require acyl chain exchange to obtain the steady-state molecular species profile of PC ([@B3]). Among the candidate genes were the two G3P acyltransferases *SCT1* (*GAT2*) and *GPT2* (*GAT1*). [Figure 1A](#F1){ref-type="fig"} shows the PC species profiles of *pct1*, *sct1pct1*, and *gpt2pct1* cells obtained by electrospray ionization tandem mass spectrometry (ESI-MS/MS) parent-ion scanning for *m/z* 184. Diunsaturated 32:2 and 34:2 PC, containing two C16:1 acyl chains and a C16:1 and a C18:1 acyl chain, respectively, were detected as the most abundant PC species. The *sct1pct1* cells ([Figure 1A](#F1){ref-type="fig"}) showed a 45% decrease in 32:1 PC (C16:1 and C16:0) compared with the *pct1* parent, which was compensated by slight increases in 34:2 and 36:2 PC. The PC species profile of the *gpt2pct1* strain was similar to that of the *pct1* strain except for a modest increase in 34:2 PC at the expense of 32:2 PC. Deletion of *SCT1* hardly affected the molecular species profile of PE, the lipid precursor of PC in *pct1* cells (Supplemental Figure S1), suggesting that *SCT1* affects the PC species profile, the level of 32:1 PC in particular, postsynthetically.

![Deletion of *SCT1* in a *pct1* strain modifies the PC species profile by impairing acyl chain exchange. (A) The PC species profiles of *pct1*, *sct1pct1*, and *gpt2pct1* cells grown to mid-log phase in SSL were analyzed by ESI-MS/MS in parent ion scans for *m/z* 184 in the positive ion mode. The relative abundance is shown for species that contribute at least 1% of total PC. Error bars represent the SD (*pct1*, n = 12; *sct1pct1* and *gpt2pct1*, n = 3). (B) *pct1* and *sct1pct1* cells cultured in SL medium were pulse labeled with deuterium-labeled methionine for 10 min, followed by a 180-min chase with an excess of methionine. The species profile of PC synthesized during the pulse was determined at the indicated time points by ESI-MS/MS in parent ion scans for *m/z* 193 and is compared with the steady-state PC species profile (*m/z* 184). The relative abundance is shown for the four major PC species as mol% of total PC. Error bars represent the SD (n = 3).](1146fig1){#F1}

To monitor postsynthetic modifications of PC, the cells were cultured on synthetic lactate medium (SL) and pulsed for 10 min with deuterium-labeled methionine, yielding PC with a (*methyl*-D~3~)~3~-labeled head group. The evolution of the molecular species profile of the newly synthesized PC during the chase with unlabeled methionine was recorded by ESI-MS/MS parent ion scans for *m/z* 193 and showed an almost twofold increase in 32:1 PC and a 20% decrease in 34:2 PC in the *pct1* strain ([Figure 1B](#F1){ref-type="fig"}, left), in agreement with [@B3]). In contrast, in the *sct1pct1* strain the molecular species profile of newly synthesized PC hardly changed during the chase ([Figure 1B](#F1){ref-type="fig"}, right), indicating that the remodeling of PC by acyl chain exchange was strongly reduced.

The expression level of catalytically active Sct1p determines the cellular C16:0 content
----------------------------------------------------------------------------------------

To elucidate the role of Sct1p in PC remodeling, we first analyzed the fatty acid composition of the deletion strains *sct1pct1* and *gpt2pct1* ([Figure 2A](#F2){ref-type="fig"}). Deletion of *SCT1* decreased the cellular content of C16:0 by ∼50%, which was compensated by an increase in C18:1. Deletion of *GPT2* did not cause major changes in fatty acid composition. Overexpression of Sct1p from an episomal *GAL1* promoter in *sct1pct1* resulted in a fourfold increase in C16:0 content and at least twofold increases in C14:0 and C18:0 at the expense of the levels of C16:1 and C18:1 ([Figure 2B](#F2){ref-type="fig"}), the overall content of saturated acyl chains increasing from ∼12 to \>40%. The level of overexpression was estimated to be at least 30-fold using Sct1p with a C-terminal HIS6HA3 tag ([Figure 2C](#F2){ref-type="fig"}). The tag did not significantly influence fatty acid composition ([Figure 2B](#F2){ref-type="fig"}). The slower-migrating band observed upon overexpression of *SCT1* ([Figure 2C](#F2){ref-type="fig"}, apparent weight ∼120 kDa) was previously assigned to the phosphorylated enzyme ([@B5]). Overexpression of a catalytically inactive form of Sct1p containing a mutation of a glycine residue in the active site (G253L; [@B31]; [@B20]) did not affect the fatty acid profile ([Figure 2, B and C](#F2){ref-type="fig"}). From these results, we conclude that the enzyme activity of Sct1p determines fatty acid desaturation. The reduced PC remodeling in *sct1pct1* is most likely a consequence of the reduced availability of C16:0.

![The expression level of catalytically active Sct1p determines the cellular content of C16:0 and affects cell growth. (A) Deletion of the *SCT1* gene decreases the cellular C16:0 content. Cells from *pct1*, *sct1pct1*, and *gpt2pct1* strains cultured in SL to mid-log phase were analyzed for fatty acid content by gas chromatography. (B) Overexpression of *SCT1* results in a fourfold increase of C16:0 content dependent on the catalytic activity of Sct1p. Cells from *sct1pct1* pYES2 (empty vector control), *SCT1pct1* pYES2 (chromosomal expression), *sct1pct1* pYES2*-SCT1* (overexpression) and *sct1pct1* pYES2*-SCT1-HH* (overexpression of tagged version), and *sct1pct1* pYES2*-SCT1\[G253L\]-HH* (overexpression of a catalytically dead mutant) strains were cultured to mid-log phase in SGR. In A and B the relative abundance (mol%) of the six major fatty acids is shown, with the error bars representing the SD for *sct1pct1* (n = 3), *sct1pct1* pYES2 (n = 4), and *pct1* pYES2 (n = 5) and the variation for the other strains (n = 2). (C) Western blots comparing the levels of HA-tagged Sct1p chromosomally expressed and episomally expressed from the *GAL1* promotor in the *pct1* background (left) and of overexpressed catalytically active and inactive Sct1p-HA in *sct1pct1 cells* (right). Dilution factors of the protein extracts are indicated (left); Sec61p served as loading control. (D) Serial dilutions of the indicated strains precultured in synthetic glucose medium were spotted on SGR agar plates and incubated at 30°C for 3 d. (E) Growth of *sct1pct1* pYES2 and *sct1pct1* pYES2*-SCT1* in liquid SGR medium supplemented with 0.05% glucose. Data averaged from four independent experiments.](1146fig2){#F2}

Overexpression of Sct1p was found to severely reduce the growth of the *sct1pct1* strain on agar plates ([Figure 2D](#F2){ref-type="fig"}). In liquid synthetic galactose-raffinose (SGR) medium containing a minimal amount of glucose, growth of the overexpression strain was reduced to a lesser extent ([Figure 2E](#F2){ref-type="fig"}). Previously, comparable growth rates in liquid culture were reported upon overexpression of Sct1p in a *gpt2sct1* double-deletion background ([@B5]).

Overexpression of Sct1p increases lipid synthesis and affects glycerolipid composition
--------------------------------------------------------------------------------------

The consequences of overexpressing Sct1p and the induced rise in C16:0 for cellular lipid content and lipid synthesis of *sct1pct1* cells were investigated by comparing the overexpression strain to the empty vector control. Overexpression of Sct1p resulted in a 1.6 ± 0.2--fold (±SD, n = 4) increase in phospholipid content based on a comparison of the amount of phosphorus recovered in cellular lipid extracts per OD~600~ unit. To investigate whether the rise in phospholipid content resulted from an increase in de novo lipid synthesis, we determined the incorporation of \[^14^C\]acetate into lipids. A 1.3 ± 0.2--fold (±SD, n = 4) increase was observed in the incorporation of \[^14^C\]acetate in the total lipid fraction per OD~600~ unit during 1 h of radiolabeling. The distribution of the \[^14^C\] label between the phospholipid and the neutral lipid fractions was not dramatically changed, with 62 ± 7% of the \[^14^C\] label associated with phospholipids in the empty vector control versus 52 ± 11% in the overexpression strain (±variation, n = 2). ESI-MS/MS analysis revealed that overexpression of Sct1p increased the level of its product lyso-PA twofold, the increase being accounted for by C16:0 lyso-PA ([Figure 3A](#F3){ref-type="fig"}). The level of phosphatidic acid (PA) increased hardly if at all, suggesting that the acylation of lyso-PA is rate limiting in PA synthesis. The molecular species profile of PA showed the appearance of disaturated PA and an increase in 32:1 and 34:1 at the expense of the diunsaturated and C18:1-containing PA species ([Figure 3A](#F3){ref-type="fig"}), consistent with the change in cellular acyl chain composition. Consistent with the overall increase in cellular lipid synthesis and content, \[^14^C\]acetate labeling showed that the synthesis of PA was increased ([Figure 3B](#F3){ref-type="fig"}). In addition, the incorporation of \[^14^C\]acetate in phosphatidylinositol (PI) and triacyl­glycerol (TAG) increased at the expense of PE and steryl ester in the phospholipid and neutral lipid classes, respectively, when Sct1p was overexpressed ([Figure 3B](#F3){ref-type="fig"}). The changes in phospholipid and neutral lipid synthesis were mirrored in the steady-state phospholipid and neutral lipid composition (Supplemental Figure S2, A and B).

![The effect of overexpressing Sct1p on the levels and molecular species profiles of lyso-PA and PA and the synthesis of phospholipids and neutral lipids. (A) *sct1pct1* cells transformed with pYES2 or pYES2*-SCT1* were grown to mid-log phase in SGR and subjected to butanol extraction, and the lyso-PA and PA species profiles were analyzed by LC-MS/MS (right). The abundance of lyso-PA and PA in pmol/mg yeast dry weight (left) represents the sum of the abundance of all corresponding species. The error bars show the variation (n = 2). (B) Mid-log *sct1pct1* cells containing pYES2 or pYES2*-SCT1* and grown in SGR were incubated with \[^14^C\]acetate for 1 h and subjected to lipid extraction. Lipids were analyzed by TLC and quantified by phosphor imaging as detailed in *Materials and Methods*. The incorporation of \[^14^C\]acetate in glycerophospholipids (left) and neutral lipids (right) is shown as percentage of the total incorporation in the respective pools, with the error bars representing the variation (n = 2). CL, cardiolipin; DAG, diacylglycerol.](1146fig3){#F3}

A comparison of the incorporation of \[^14^C\]acetate in the lipids of *pct1* and *sct1pct1* cells cultured in SL medium did not reveal differences in total lipid synthesis, in the distribution of label between neutral lipids and phospholipids, and in the relative incorporation into different phospholipid classes. The relative incorporation of \[^14^C\]acetate into the neutral lipid classes was similar to that reported previously for an *sct1* deletion strain and its parental wild type ([@B59]), with an increase in the synthesis of TAG in *pct1* versus *sct1pct1* that was comparable to the increase induced by overexpression of Sct1p in *sct1pct1* (Supplemental Figure S2C and [Figure 3](#F3){ref-type="fig"}).

Similar to PA ([Figure 3A](#F3){ref-type="fig"}), the molecular species profiles of the four major phospholipid classes revealed increased saturation upon Sct1p overexpression (Supplemental Figure S3), with rises in monounsaturated species predominating in PC and PE, and rises in disaturated species in phosphatidylserine (PS) and PI, all at the expense of the diunsaturated species. The increase in acyl chain saturation was strongest in PC, followed in decreasing order by PS, PI, and PE (Supplemental Figure S3C).

Co-overexpression of Sct1p and Ole1p reveals competition for the common substrate C16:0-CoA
-------------------------------------------------------------------------------------------

The enzyme activity of Sct1p could enhance fatty acid saturation by sequestering C16:0 chains into lipids, thus depriving the desaturase Ole1p of its C16:0-CoA substrate. To address this possibility, we co-overexpressed Sct1p and Ole1p. Whereas overexpression of Sct1p caused a decrease in fatty acid desaturation as described earlier, overexpression of Ole1p increased fatty acid desaturation and slightly enhanced fatty acid length ([Figure 4A](#F4){ref-type="fig"}). Co-overexpression gave rise to a fatty acid profile intermediate between those of the single-overexpression strains ([Figure 4A](#F4){ref-type="fig"}). The expression level of Ole1p-Myc was similar in strains where pESC*-OLE1* was cotransformed with pYES2 or pYES2*-SCT1-HH* ([Figure 4B](#F4){ref-type="fig"}), and the expression level of Sct1p in *sct1pct1* pYES2-*SCT1-HH* was not affected by cotransformation of pESC*-OLE1* (unpublished data). Similar fatty acid profiles were obtained when an Ole1p-Myc--overexpressing strain was cotransformed with the vector encoding the His6HA3-tagged version of Sct1p (Supplemental Figure S4). Taken together, these results indicate that the two enzymes compete for the shared substrate C16:0-CoA.

![Co-overexpression of Ole1p and Sct1p reveals competition for the shared substrate C16:0-CoA. (A) *sct1pct1* cells transformed with the indicated plasmids were cultured to mid-log phase in SGR and analyzed for their fatty acid contents by gas chromatography. The relative abundance (mol%) of the six major fatty acids and of total saturated fatty acids is shown, with the error bars representing the variation (n = 2). (B) Western blot analysis of the Ole1p expression levels of *sct1pct1* pYES2 + pESC*-OLE1* and *sct1pct1* pYES2*-SCT1-HH* + pESC*-OLE1*. (c) Serial dilutions of *sct1pct1* cells transformed with the plasmids indicated and precultured in synthetic glucose medium were spotted on SGR plates and incubated at 30°C for 3 d.](1146fig4){#F4}

Co-overexpression of Sct1p and Ole1p partially relieved the growth defect of cells overexpressing Sct1p ([Figure 4C](#F4){ref-type="fig"}). Overexpression of Ole1p slightly impaired growth.

The growth phenotype and increased C16:0 content induced by overexpression of Sct1p are suppressed by deletion of the *ACB1* and *CST26* genes; Cst26p affects phosphorylation and expression of Sct1p
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

To get further insight in the mechanism by which Sct1p regulates fatty acid saturation and its biological significance, we screened for suppressors of the growth phenotype caused by overexpression of Sct1p. The screen comprised 10 double-knockout strains in which a gene involved in lipid metabolism was deleted in the *pct1* background and yielded two suppressors.

Deletion of *ACB1*, coding for the yeast acyl-CoA--binding protein that has been implicated in the termination of fatty acid synthesis and in fatty acid elongation ([@B50]; [@B14]), partially restored the growth defect ([Figure 5A](#F5){ref-type="fig"}, left) and partially reduced the accompanying rise in C16:0 content ([Figure 5B](#F5){ref-type="fig"}) conferred by overexpression of Sct1p. Immunoblot analysis verified that the level of overexpression of Sct1p was not affected by deletion of *ACB1* ([Figure 5C](#F5){ref-type="fig"}). Closer inspection of the fatty acid profiles ([Figure 5B](#F5){ref-type="fig"}) reveals the shortening and increased unsaturation of the acyl chains characteristic of *acb1* strains ([@B8]). Deletion of *ACB1* was previously shown to be accompanied by a \>5-fold activation of *OLE1* transcription ([@B8]; [@B50]). Therefore the partial suppression of the Sct1p overexpression phenotype in *acb1pct1* cells, that is, under conditions where untagged Ole1p is expressed from its endogenous promoter, supports our conclusion that competition between Sct1p and Ole1p for C16:0-CoA determines cellular fatty acid saturation.

![The growth phenotype and increased C16:0 content induced by overexpression of Sct1p are suppressed by deletion of the *ACB1* and *CST26* genes; Cst26p affects phosphorylation and expression of Sct1p. (A) Serial dilutions of the indicated strains precultured in synthetic glucose medium were spotted on SGR plates and incubated at 30°C for 5 d. (B) Cells from the indicated strains cultured to mid-log phase in SGR were analyzed for fatty acid contents by gas chromatography. The relative abundance (mol%) of the six major fatty acids is shown, with the error bars representing the SD for *pct1* (n = 5) and the variation for *acb1pct1* and *cst26pct1* (n = 2). (C) Western blot analysis of Sct1p-HA expressed from pYES2*-SCT1-HH* in the strains indicated.](1146fig5){#F5}

It is surprising that deletion of *CST26/PSI1* fully suppressed the growth phenotype ([Figure 5A](#F5){ref-type="fig"}, right) and the increase in fatty acid saturation ([Figure 5B](#F5){ref-type="fig"}) induced by Sct1p overexpression. *CST26* codes for a 46-kDa protein with homology to acyltransferases ([@B39]) that is localized to lipid particles ([@B38]) and is required for the incorporation of stearic acid (C18:0) into PI ([@B30]). Of interest, the *cst26pct1* cells exhibited a decrease in C18 content relative to the *pct1* strain ([Figure 5B](#F5){ref-type="fig"}). Western blot analysis of the level of overexpression of tagged Sct1p showed at least twofold decrease in the total Sct1p--hemagglutinin (HA) signal in *cst26pct1* as compared with *pct1* and *sct1pct1* ([Figure 5C](#F5){ref-type="fig"}, right). Moreover, the migration pattern of overexpressed Sct1p-HA in *cst26pct1* cells differed from that in *pct1* and *sct1pct1* cells, with the upper band (apparent molecular weight 120 kDa) containing 85% of the total Sct1p-HA signal in *cst26pct1* versus 55% in *pct1* and *sct1pct1*, as determined by densitometry. Because the upper band was shown to correspond to the phosphorylated enzyme ([@B5]), these findings strongly suggest that phosphorylation inactivates Sct1p and that Cst26p regulates (de)phosphorylation of Sct1p.

We conclude that deletion of *CST26* fully suppresses the growth phenotype and increase in C16:0 content conferred by overexpression of Sct1p by a mechanism that most likely involves inactivation of Sct1p by increased phosphorylation and decreased expression.

Phosphorylation of Sct1p is enhanced by the presence of C16:0 in the culture medium
-----------------------------------------------------------------------------------

The foregoing results indicate that the level of expression and the phosphorylation state of Sct1p are potentially critical parameters in regulating fatty acid desaturation. To examine whether yeast uses these regulatory mechanisms to control the activity of chromosomally expressed Sct1p, we monitored the expression of chromosomally HIS6HA3-tagged Sct1p under conditions known to influence fatty acid composition. Varying the growth temperature from 30 to 37°C or the carbon source (glucose vs. lactate; [@B36]) did not affect the expression level or phosphorylation state of Sct1p (Supplemental Figure S5). A more straightforward way to alter the fatty acid composition is by supplementing fatty acids to the culture medium. A slow-migrating band appeared upon addition of C16:0 to wild-type (WT) cells in yeast extract/peptone/dextrose (YPD), and the intensity of the slow-migrating band increased twofold upon addition of C16:0 to *pct1* cells in synthetic glucose medium ([Figure 6](#F6){ref-type="fig"}). In contrast, addition of C18:1 did not affect the migration pattern of Sct1p-HA. Densitometric analysis of the blots revealed that 10 and 30% of Sct1p-HA were phosphorylated in the WT and *pct1* cells grown in the presence of C16:0, respectively, versus 0 and 15% with no added fatty acid or C18:1 present.

![The level of phosphorylation of Sct1p is enhanced by the presence of C16:0 in the culture medium. Wild-type (BY4741 *SCT1HH*) cells were grown to mid-log phase in YPD containing 1% (wt/vol) Brij35 with or without 0.5 mM C16:0 or 0.5 mM C18:1. *pct1 SCT1HH* cells were grown to mid-log phase in synthetic glucose medium with 0.2% Brij35 with or without 0.1 mM C16:0 or 0.1 mM C18:1. FA, fatty acid.](1146fig6){#F6}

DISCUSSION
==========

On the basis of the results presented, we propose a new mechanism for the control of fatty acid desaturation at the level of acyl chain incorporation into PA that is juxtaposed to the regulation of Ole1p activity ([@B36]). We propose that Sct1p shields C16:0-CoA and other saturated acyl-CoA\'s from the introduction of a double bond by Ole1p by preferentially sequestering them into lipids ([Figure 7](#F7){ref-type="fig"}). We furthermore propose that the competition for substrate with the desaturase Ole1p is determined by the activity of Sct1p, which in turn depends on the expression level and the phosphorylation state of the enzyme. In the following we discuss the new competition model and the regulation of Sct1p activity by phosphorylation, including the role of Cst26p, the growth phenotype of Sct1p overexpression strains, the effects of *SCT1* deletion and overexpression on lipid metabolism, and the implications of our findings for yeast and higher eukaryotes.

![Proposed mechanism for regulation of fatty acid desaturation by competition for C16:0-CoA between Sct1p and Ole1p. C16:0-CoA synthesized by the fatty acid synthase is sequestered into lipids by Sct1p and possibly other acyltransferases, decreasing desaturation (orange). Alternatively, Ole1p introduces a double bond, yielding C16:1-CoA and increasing desaturation (green). The elongases produce C18:0-CoA, which can be incorporated into lipids by Sct1p or other acyltransferases or converted into C18:1-CoA by Ole1p. Free fatty acids originating from lipid degradation by lipases recycle into the acyl-CoA pool after activation by acyl-CoA synthetases. To reduce complexity, elongation of acyl-CoA beyond C18 and metabolic fates of acyl-CoA\'s other than incorporation into lipids are omitted in the diagram.](1146fig7){#F7}

A new paradigm for regulation of fatty acid desaturation involving competition between a desaturase and an acyltransferase
--------------------------------------------------------------------------------------------------------------------------

Although the competition for substrate between Sct1p and Ole1p primarily revolves around C16:0-CoA, the preferred substrate of Sct1p in vivo ([@B60]), our results indicate that also C18:0-CoA and C14:0-CoA are subject to competition between Sct1p and Ole1p ([Figures 2B](#F2){ref-type="fig"} and [4A](#F4){ref-type="fig"}). Overexpression of Ole1p caused an increase in average acyl chain length, as was observed previously ([@B23]), suggesting that Ole1p promotes elongation to C18:0-CoA by efficient desaturation to C18:1-CoA. Consistently, a shortening of fatty acids was observed upon ablation of unsaturated fatty acid synthesis ([@B43]). Overexpression of Sct1p was found to decrease the average cellular fatty acid length, suggesting that Sct1p also competes for substrate with the fatty acid elongases that use C16:0-CoA as substrate, although it must be noted that the role of the fatty acid elongases in the synthesis of C18:0-CoA is not fully established ([@B46]). According to the proposed mechanism, the substrate preferences and the activities of Sct1p, Ole1p, and the fatty acid elongases determine the cellular fatty acid composition ([Figure 7](#F7){ref-type="fig"}). The influence of additional enzymes that consume large amounts of acyl-CoA, including the other enzymes involved in PA synthesis, Gpt2p, Ale1p, and Slc1p, remains to be investigated. The fatty acid composition of the *gpt2* deletion strain ([Figure 2A](#F2){ref-type="fig"}) and its reported lack of substrate preference ([@B60]) suggest that Gpt2p is not a major player in regulating the degree of fatty acid desaturation.

Phosphorylation of Sct1p inhibits its activity in vivo and is regulated by Cst26p
---------------------------------------------------------------------------------

The G3P acyltransferases Sct1p and Gpt2p were recently demonstrated to be phosphoproteins, and phosphorylation was proposed to regulate their activity ([@B5]). The enhanced phosphorylation of Sct1p and the accompanying complete reversal of the increased acyl chain saturation observed in the *cst26* strain overexpressing *SCT1* indicate that Sct1p is inactivated by phosphorylation. Preliminary experiments addressing the mechanism by which phosphorylation affects Sct1p activity showed that treatment with phosphatase of cell homogenates from an Sct1p-overexpressing strain does not affect the enzyme activity in vitro, suggesting that phosphorylation exerts an indirect effect on Sct1p activity in vivo, for example, by affecting access to substrate. The decrease in expression level of overexpressed Sct1p in the *cst26* background may be a consequence of degradation of the phosphorylated enzyme. The functional significance of Sct1p phosphorylation in determining yeast fatty acid composition is evidenced by the increase in phosphorylation of chromosomally expressed Sct1p following exogenous addition of C16:0. Yeast has been shown to readily incorporate exogenous C16:0 in glycerolipids ([@B57]). The modulation of Sct1p phosphorylation could provide a feedback mechanism by which yeast controls the incorporation of saturated acyl chains into its lipids.

A number of key enzymes in yeast lipid biosynthesis, including CTP synthase, PS synthase, and choline kinase, are regulated by phosphorylation involving protein kinases A and C ([@B7]). Recently the Mg^2+^-dependent PA phosphatase Pah1p was found to be inactivated by phosphorylation of an amphipathic helix that controls membrane translocation ([@B41]; [@B25]). The major lipase Tgl4p that mobilizes free fatty acids from TAG for the synthesis of PA is activated by the cyclin-dependent kinase Cdk1p/Cdc28p, linking lipid synthesis to the cell cycle ([@B28]). A genome-wide screen identified 16 kinases that use Sct1p as a substrate in vitro, including the cyclin-dependent kinase Pho85p and the p21-activated kinase Ste20p ([@B45]). Ste20p was linked to lipid metabolism, as it downregulates sterol uptake ([@B32]) and binds to and is activated by PA ([@B21]). Therefore it is tempting to speculate that Ste20p phosphorylates and deactivates Sct1p as PA levels rise, which would implicate Ste20p in the regulation of fatty acid desaturation in addition to its role in sterol homeostasis. Future research should identify the kinase(s) and phosphatase(s) acting on Sct1p and elucidate how its regulation by phosphorylation interfaces with other regulatory cascades.

It is remarkable that Cst26p was found to be required for maintaining the dephosphorylated state of Sct1p under conditions of Sct1p overexpression. Cst26p/Psi1p was only recently identified as an acyl-CoA--dependent acyltransferase involved in the acyl chain remodeling of PI, incorporating C18:0 at the *sn*-1 position ([@B30]). The decreased cellular C18 content in *cst26pct1* ([Figure 5B](#F5){ref-type="fig"}) is consistent with the loss of C18:0-CoA consumption by Cst26p reducing the activity of the elongases by a decrease in the substrate-to-product ratio. The inactivation of overexpressed Sct1p upon deletion of *CST26* could reflect a feedback mechanism to decrease the cellular content of saturated fatty acids when their incorporation into PI is impaired. Cst26p may inhibit the kinase or activate the phosphatase acting on Sct1p via its impact on the molecular species profile of PI or downstream phosphoinositides. Alternatively, Cst26p may be a dual-function protein with independent roles in PI metabolism and in the regulation of Sct1p activity.

Growth defect and adaptation of membrane lipid composition
----------------------------------------------------------

The extent of the decrease in fatty acid desaturation correlates with the severity of the reduction of growth in the co-overexpression experiment ([Figure 4](#F4){ref-type="fig"}), indicating that the increased acyl chain saturation plays a pivotal role in the growth defect conferred by Sct1p overexpression. The dramatic increase in fatty acyl chain saturation probably reduces membrane fluidity, impairing membrane processes. The growth phenotype and the increase in fatty acid saturation observed in liquid culture ([Figure 2](#F2){ref-type="fig"}) resemble the effects of switching off fatty acid desaturation by inactivating heme synthesis ([@B43]), a condition inducing ER stress ([@B44]).

Overexpression of Sct1p results in increased synthesis of PA and a consequent overall increase in cellular lipid content. In contrast to deletion of *SCT1*, overexpression does not affect the relative rates of synthesis of TAG versus sterolesters in the neutral lipid fraction ([@B59]). Among the glycerophospholipids, the synthesis of PI increases at the expense of PE. The PI synthase Pis1p may have a preference for C16:0-containing CDP-DAG and hence convert more CDP-DAG into PI upon Sct1p overexpression. Alternatively, the increase in PA synthesis due to Sct1p overexpression may derepress the UAS~INO~ genes, enhancing the production of inositol, which in turn promotes the synthesis of PI at the expense of PS, the biosynthetic precursor of PE ([@B26]; [@B34]). Irrespective of the mechanism involved, lowering the PE content contributes to maintaining membrane fluidity when yeast faces a rise in saturated acyl chains, as the smaller dimensions of the PE head group allow tighter packing of acyl chains than the head groups of other phospholipids ([@B53]). Cells overexpressing Sct1p not only reduce their PE content, but also seem to protect PE from the excess of C16:0, as the change in saturation is smaller in PE than in the other major phospholipids. The rise in PI/PE ratio in response to increased saturation is fully consistent with the finding that overexpression of PI synthase suppresses the growth defect conferred by a mutation in the *RSP5* gene impairing fatty acid desaturation ([@B24]).

It is worth noting that the increase of C16:0 in PE reduces its nonbilayer propensity ([@B27]; [@B4]). As a consequence, overexpression of Sct1p renders PE more suitable as a bilayer-forming lipid, which may account for the discovery of the *SCT1* gene as a multicopy suppressor of a mutant defective in PC synthesis ([@B37]). The increase in fatty acid saturation probably allowed PE to substitute for PC and rescue cell growth. This is to our knowledge the first time that these results receive an adequate explanation.

PC is the preferred phospholipid for accommodating C16:0 upon overexpression of Sct1p in the *pct1*-deletion background. In the absence of an active CDP-choline route, PC acquires C16:0 acyl chains from its precursor PE and by acyl chain remodeling ([Figure 1B](#F1){ref-type="fig"}). Compared to the methylation of PE, the CDP-choline route more readily incorporates C16:0 into PC ([@B3]). The latter property may account for the connection between turnover of PC through the CDP-choline route and Sct1p activity reported previously. Deletion of *SCT1* was shown to result in a 10-fold decrease in the turnover of PC through the CDP-choline route, whereas deletion of *GPT2* caused a fivefold increase in turnover of PC through the CDP-choline route ([@B59]). Our observation that the extent of phosphorylation of chromosomally expressed Sct1p is higher in *pct1* than in wild-type cells ([Figure 6](#F6){ref-type="fig"}) may reflect this connection. Taken together, these findings substantiate the incorporation of C16:0 into PC as an adaptation to changes in fatty acid composition and assign PC a function as reservoir of C16:0. Of interest, mutants disturbed in the synthesis of TAG become sensitive to exogenous C16:0 when the PE methylation pathway is inactivated ([@B15]).

Regulation of fatty acid desaturation in mammalian cells may involve a glycerol-3-phosphate acyltransferase
-----------------------------------------------------------------------------------------------------------

Mammalian cells harbor 4 glycerol-3-phosphate acyltransferase (GPAT) isozymes, mitochondrial GPAT1 and GPAT2 and microsomal GPAT3 and GPAT4, which contain the same active-site motifs as their yeast functional homologues ([@B31]; [@B58]). GPAT1 seems to have a specificity for C16:0-CoA similar to that of Sct1p ([@B18]), whereas the other GPATs do not show pronounced substrate preferences. Of interest, GPAT1-deficient mice display a reduced stearoyl-CoA desaturase 1 (SCD1) expression ([@B19]), and overexpression of GPAT1 in mice specifically induces expression of SCD1 by an unknown mechanism not secondary to increased de novo lipogenesis ([@B33]). These observations are consistent with regulation of SCD1 in response to changes in fatty acid saturation conferred by GPAT1 and hint at a mechanism of competition for substrate between GPAT1 and SCD1 similar to that between Sct1p and Ole1p in yeast. Disturbances in the expression level and function of GPAT1 and SCD1 and the resulting variation in fatty acid desaturation have been implicated in apoptosis, insulin resistance, and obesity, stressing the importance of a proper balance between saturated and unsaturated fatty acids ([@B42]; [@B40]; [@B9]; [@B17]). The present study provides evidence that the activity of a G3P acyltransferase is a novel parameter in maintaining this balance.

MATERIALS AND METHODS
=====================

Strains and culture conditions
------------------------------

The yeast strains listed in [Table 1](#T1){ref-type="table"} were maintained on YPD agar plates (1% yeast extract, 2% bactopeptone, and 2% glucose). Strains harboring the pYES2 and/or pESC-HIS plasmids were obtained using the high-efficiency transformation protocol ([@B16]) and maintained on plates containing synthetic glucose medium lacking uracil and/or histidine, respectively. Synthetic medium contained the following per liter: 6.7 g of yeast nitrogen base without amino acids (Difco, Franklin Lakes, NJ), 20 mg of adenine, 20 mg of arginine, 20 mg of histidine, 60 mg of leucine, 230 mg of lysine, 20 mg of methionine, 300 mg of threonine, 20 mg of tryptophan, 40 mg of uracil, and either 20 g of glucose (synthetic glucose medium) or 22 ml of 90% (vol/vol) lactic acid and 1 g of glucose, adjusted to pH 5.5 using KOH (SL). Strains were cultured aerobically at 30°C in semisynthetic lactate medium (SSL; [@B10]) or in SL. Strains containing the pYES2 and/or pESC-HIS plasmids were cultured in synthetic glucose medium without uracil and/or histidine, respectively, for 24 h, and then shifted to SGR medium containing 1% raffinose and 2% galactose at OD~600~ 0.02 to induce the *GAL1* promoter and cultured for another 24 h. Growth was monitored by measuring the OD at 600 nm on a single-beam spectrophotometer (Novaspec II; Pharmacia, GE Healthcare, Piscataway, NJ). Cells were harvested at mid-logarithmic growth phase (OD~600~ between 0.3 and 0.7).

###### 

Yeast strains and plasmids used in this study.

  Strain/plasmid            Genotype                                                                                                      Source
  ------------------------- ------------------------------------------------------------------------------------------------------------- ------------
  BY4741                    *MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0*                                                                           EUROSCARF
  *sct1*                    Isogenic to BY4741 except *sct1::kanMX4*                                                                      EUROSCARF
  *gpt2*                    Isogenic to BY4741 except *gpt2::kanMX4*                                                                      EUROSCARF
  *acb1*                    Isogenic to BY4741 except *acb1::kanMX4*                                                                      EUROSCARF
  *cst26*                   Isogenic to BY4741 except *cst26::kanMX4*                                                                     EUROSCARF
  *pct1*                    Isogenic to BY4741 except *pct1::LEU2*                                                                        This study
  *sct1pct1*                Isogenic to BY4741 except *pct1::LEU2 sct1::kanMX4*                                                           This study
  *gpt2pct1*                Isogenic to BY4741 except *gpt2::kanMX4 pct1::LEU2*                                                           This study
  *acb1pct1*                Isogenic to BY4741 except *acb1::kanMX4 pct1::LEU2*                                                           This study
  *cst26pct1*               Isogenic to BY4741 except *cst26::kanMX4 pct1::LEU2*                                                          This study
  BY4741 *SCT1-HH*          Isogenic to BY4741 except *SCT1-6His-3HA-loxP-KanMX-loxP*                                                     This study
  *pct1 SCT1-HH*            Isogenic to BY4741 *SCT1-HH* except *pct1::LEU2*                                                              This study
  pYES2                     High copy vector containing the *GAL1* promoter and the *URA3* gene                                           Invitrogen
  pYES2*-SCT1*              pYES2 containing the *SCT1* gene                                                                              [@B60]
  pYES2*-SCT1-HH*           pYES2 containing the *SCT1* gene with a C-terminal His6-HA3 tag                                               This study
  pYES2*-SCT1\[G253L\]HH*   pYES2 containing the *SCT1* gene with a C-terminal His6-HA3 tag and a Gly to Leu mutation at amino acid 253   This study
  pESC-HIS                  High copy vector containing *GAL1* and *GAL10* promoters and the *HIS3* gene                                  Stratagene
  pESC*-OLE1*               pESC-HIS containing the *OLE1* gene with a C-terminal *Myc* tag behind the *GAL1* promoter                    This study

EUROSCARF, European *Saccharomyces cerevisiae* Archive for Functional Analysis,

Institute of Molecular Biosciences, Johann Wolfgang Goethe-University Frankfurt, Frankfurt, Germany.

Growth phenotypes were analyzed by culturing cells to mid-log phase in synthetic glucose medium, washing them twice with water, and spotting 15 μl of cell suspension serially diluted to OD~600~ values of 10^−1^, 10^−2^, 10^−3^, 10^−4^, and 10^−5^ onto agar plates containing SGR. Plates were incubated at 30°C for 2--5 d as indicated.

To compare Sct1p expression patterns in the presence and absence of exogenous fatty acids, cells were cultured for 16 h in YPD or synthetic glucose medium and then transferred to YPD containing 1% (wt/vol) Brij35 with or without 0.5 mM C16:0 or 0.5 mM C18:1, or to synthetic glucose medium containing 0.2% Brij35 with or without 0.1 mM C16:0 or 0.1 mM C18:1 at OD~600~ 0.002. Cells were grown for another 24 h, harvested at mid-logarithmic growth phase, and subjected to Western blotting as described later.

Molecular biology
-----------------

The *PCT1* gene was deleted in the strains BY4741, *sct1, gpt2*, *acb1*, and *cst26* ([Table 1](#T1){ref-type="table"}) to yield the corresponding knockout strains by *LEU2* insertion in PCR-mediated gene disruption using primers PCT1-LEU2-1 and -2 (Supplemental Table S1) as previously described ([@B3]).

Chromosomal *SCT1* was tagged with a *His6HA3* epitope by amplification of the *6His-3HA-loxP-KanMX-loxP* cassette from the pU6H3HA plasmid ([@B11]) with primers SCT1-HH-1 and -2 (Supplemental Table S1) and subsequent insertion in the BY4741 and *pct1* strains ([Table 1](#T1){ref-type="table"}).

The pYES2 (Invitrogen, Carlsbad, CA) and pESC-HIS (Stratagene, Santa Clara, CA) vectors were used to construct galactose-inducible overexpression vectors in which the expression of His6HA3-tagged Sct1p and Myc-tagged Ole1p was under control of the *GAL1* promoter ([Table 1](#T1){ref-type="table"}). The pYES2*-SCT1-HH* overexpression vector was constructed by amplification of *SCT1-6His-3HA* from *pct1 SCT1-HH* chromosomal DNA using primers pYES-SCT1-1 and -2 (Supplemental Table S1) and insertion of the amplified fragment into the *Bam*HI and *Xho*I restriction sites of pYES2 ([Table 1](#T1){ref-type="table"}). The pESC-*OLE1* vector was constructed by amplification of *OLE1* from BY4741 chromosomal DNA with primers pESC-OLE1-1 and -2 and insertion of the amplified fragment into the *Apa*I restriction site of pESC-HIS plasmid (Stratagene)

An inactive version of His6HA3-tagged Sct1p was obtained by introducing a mutation of Gly to Leu in the active site (Supplemental Table S1; [@B31]; [@B20]). Site-directed mutagenesis was performed using a QuikChange Site-Directed Mutagenesis Kit (Stratagene) with the pYES2*-SCT1-HISHA* plasmid and primers SCT1-G253L-1 and -2 to construct the pYES2*-SCT1\[G253L\]-HISHA* vector ([@B20]).

Correct integration of PCR-amplified fragments in the genome was verified by PCR. Correct amplification of the genes inserted in the vectors was verified by DNA sequencing.

Pulse-chase labeling with deuterium-labeled methionine
------------------------------------------------------

Cells grown to mid-log phase in SL medium were collected by filtration, washed with amino acid--free SL, and resuspended at OD~600~ 0.2--0.4 in 300 ml of SL medium supplemented with 120 mg/l (0.78 mM) (*methyl*-[d]{.smallcaps}~3~)-[l]{.smallcaps}-methionine (Cambridge Isotope Laboratories, Andover, MA) instead of 20 mg/l [l]{.smallcaps}-methionine. After 10 min, cells were collected by filtration, washed with amino acid--free SL, and transferred within 3 min to 250 ml SL medium supplemented with 300 mg/l [l]{.smallcaps}-methionine, and incubation at 30°C was continued. At various time points, 50-ml aliquots of cell culture were collected, inactivated by adding KCN, NaF, and NaN~3~ at 15 mM each, and stored on ice until further processing. All media used for washing and resuspension were at 30°C.

Lipid analysis by mass spectrometry
-----------------------------------

Cell homogenates were obtained by vortexing yeast cells corresponding to ∼25 OD~600~ units in the presence of glass beads ([@B3]) and subjected to lipid extraction ([@B2]). Total lipid extracts corresponding to 300 nmol of phospholipid-phosphorus ([@B47]) were dissolved in 200 μl of chloroform:methanol 1:1 (vol/vol) containing 10 mM ammonium acetate and analyzed by ESI-MS/MS on an API3000 triple quadrupole instrument (Applied Biosystems, Foster City, CA). Samples were injected into the instrument with a Hamilton Gastight 1710 syringe and a Harvard Apparatus Pump 11 at a constant flow rate of 3 μl/min. PC and (*methyl*-D~3~)~3~-PC were detected in parent ion scans for *m/z* 184 and 193, respectively, in the positive ion mode, PE in neutral loss scans for 141 atomic mass units in the positive ion mode, PI in parent ion scans for *m/z* 241 in the negative ion mode, and PS in neutral loss scans for 87 atomic mass units in the negative ion mode. Other settings were as previously described ([@B6]). Signal intensities were quantified using Analyst software (Applied Biosystems/MDS Sciex, Toronto, Canada), taking into account the three most abundant \[M + H\]^+^ isotopic signals. An equimolar mixture of biologically relevant PC species (Avanti Polar Lipids, Alabaster, AL) indicated that the signal intensities are representative of the relative abundance of PC species under the conditions used. Yeast samples destined for analysis of lyso-PA and PA were lyophilized and subjected to butanol extraction and liquid chromatography-tandem mass spectrometry (LC-MS/MS) as described ([@B48], [@B49]).

Fatty acid analysis
-------------------

Yeast total lipid extracts prepared as earlier and corresponding to 1 μmol of phospholipid phosphorus were transesterified by heating at 70°C for 2 h in 2.5% (vol/vol) H~2~SO~4~ in methanol. The fatty acid methylesters were extracted in hexane and separated on a Trace GC ultra gas chromatograph (Thermo Electron, Interscience, Louvain-la-Neuve, Belgium) using a Restek Stabilwax column and a temperature gradient from 170 to 210°C. Fatty acid methylesters were identified and signal intensities were calibrated using a fatty acid methylester standard (Nu-Chek-Prep, Elysian, MN).

\[^14^C\]Acetate labeling and analysis of lipid composition by thin-layer chromatography
----------------------------------------------------------------------------------------

Cells grown to mid-log phase at 30°C in 5 ml of SGR medium without uracil were labeled with 75 μCi 1-\[^14^C\]acetate (56 mCi/mmol, GE Healthcare) for 1 h at 30°C, harvested by centrifugation, and resuspended in 1 ml 5% trichloroacetic acid. Subsequently cells were pelleted, washed twice with water, homogenized, and subjected to lipid extraction as described. Lipid extracts were subjected to liquid scintillation counting, determination of total phospholipid-phosphorus content ([@B47]), and analysis of neutral lipid and phospholipid composition by thin-layer chromatography (TLC; [@B12]; [@B52]). The radioactive spots on the TLC plates were visualized and quantified using a Personal Molecular Imager FX PhosphorImager (Bio-Rad, Hercules, CA). Steady-state phospholipid and neutral lipid composition was analyzed by TLC ([@B12]; [@B52]) using lipid extracts corresponding to 300 nmol of phospholipid-phosphorus. Spots were visualized with I~2~ vapor, and phospholipid-containing spots were scraped off. The amount of inorganic phosphorus in TLC spots was measured according to [@B47]) after destruction in 70% perchloric acid for 3 h at 180°C.

Western blotting
----------------

Logarithmically growing cells were harvested, washed, resuspended in 0.1 M NaOH, and incubated at room temperature for 5 min, pelleted, resuspended in SDS--PAGE sample buffer containing 4% β-mercaptoethanol, and incubated for 4 min at 95°C ([@B29]). Samples corresponding to 10 μg of protein (as determined by the Pierce BCA protein assay kit \[Thermo Fisher Scientific, Rockford, IL\], using Pierce YPER as detergent and bovine serum albumin as a standard) were analyzed by 10% SDS--PAGE followed by Western blotting with antibodies against HA (mouse anti-HA 12CA5; Roche Diagnostics, Indianapolis, IN), Myc (mouse anti--c-Myc immunoglobulin 9E10, sc-40; Santa Cruz Biotechnology, Santa Cruz, CA), and Sec61p (a kind gift from R. Schekman, University of California, Berkeley, CA), using horseradish peroxidase--conjugated secondary antibodies, followed by detection with SuperSignal West Pico Chemiluminescent Substrate (Pierce). Densitometry was performed using ImageJ software (National Institutes of Health, Bethesda, MD).
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G3P

:   glycerol-3-phosphate

GPAT

:   glycerol-3-phosphate acyltransferase

ESI-MS/MS

:   electrospray ionization tandem mass spectrometry

LC-MS/MS

:   liquid chromatography-tandem mass spectrometry

lyso-PA

:   lysophosphatidic acid

PA

:   phosphatidic acid

PC

:   phosphatidylcholine

PE

:   phosphatidylethanolamine

PI

:   phosphatidylinositol

PS

:   phosphatidylserine

SGR

:   synthetic galactose-raffinose medium

SL

:   synthetic lactate medium

SSL

:   semisynthetic lactate medium

TAG

:   triacylglycerol

TLC

:   thin-layer chromatography
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